content

The New Nebula® Multimode Reader from Lonza Streamlines Quantitative Endotoxin Detection

Lonza has launched the Nebulaยฎ Multimode Reader, the first multimode reader qualified for use with Lonzaโ€™s turbidimetric, chromogenic and recombinant endotoxin detection methods. Users...

Frontier Biotechnologies Announces Positive Phase 1 Results of its First Coronavirus Main Protease (MPRO) Small Molecule Inhibitor

Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the...

Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be showcasing its large portfolio of solutions available to customers in India at...

Baxter Pharmaceuticals India celebrates five years of operations in Ahmedabad, India

Baxter Pharmaceuticals India Private Limited (BPIPL), Ahmedabad based generic injectables manufacturing facility has successfully completed five years of its robust presence in India. The...

AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod

AstraZenecaย (AZN.L)ย and Daiichi Sankyoย (4568.T)ย on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way...

The future of high-throughput screening

High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific...

85mn Pandemic Flu Vaccines To Be Supplied By GSK To Europe

Adjupanrix, aย pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read